Call Us 866.600.CARE

Ajay V. Maker MD

Dr. Ajay V. MakerSurgical Oncology

Associate Professor of Surgery and Microbiology/Immunology, Director of Surgical Research UIC-MGH Surgical Residency Program


Dr. Maker is a surgical oncologist with board certification in general surgery. His expertise include treating benign and malignant diseases of the liver, bile ducts, gallbladder and pancreas, as well as colon and other gastrointestinal cancers, melanoma, and sarcoma. He joined the Division of Surgical Oncology and the Department of Microbiology and Immunology at the University of Illinois at Chicago after completing a fellowship in surgical oncology with a focus upon hepatopancreatobiliary surgery at Memorial Sloan-Kettering Cancer Center, and a fellowship in Tumor Immunology and Surgical Oncology at the National Cancer Institute. Dr. Maker cares for patients as part of a multidisciplinary team of medical oncologists, radiation oncologists, gastroenterologists, and radiologists who specialize in treating patients with these specific cancers.


  • Fellowship: Memorial Sloan-Kettering Cancer Center, Surgical Oncology; National Cancer Institute/NIH, Surgical Oncology
  • Residency: Brigham and Women's Hopsital/Harvard Medical School, General Surgery
  • Internship: Brigham and Women's Hopsital/Harvard Medical School, General Surgery
  • Medical School:Yale University School of Medicine
  • Undergraduate School: Brown University

Board Certified

General Surgery


Spanish (Basic)

Research Interests

Dr. Maker's research focuses on cancers of the colon and liver. During his surgical residency at the Brigham and Women's Hospital, he spent two years performing translational immunotherapy research with Dr. Steven Rosenberg at the National Institutes of Health, where he and his colleagues were of the first to identify the utility of an anti-CTLA4 antibody as an anti-cancer treatment for patients with metastatic melanoma, and investigated its immunological mechanism of action. His clinical research has involved identifying immunologic markers of cancer in pancreatic cystic tumors.

In his laboratory at UIC, he and his colleagues continue to focus on studying the role of the immune system in cancer, specifically on colon cancer that has spread to the liver. He is working towards identifying novel immunotherapeutic agents for these conditions and initiating clinical trials to investigate them. His research has been supported by several grants, including the WCCAB Career Development Award. He is also a primary investigator on a multi-year grant from the National Institute of Health/Cancer Institute.

Dr. Maker has served as a reviewer and editor for multiple scientific and clinical journals. He is also a member of the numerous societies, including the Society of Surgical Oncology, American Society of Clinical Oncology, American College of Surgeons, Americas Hepatopancreatobiliary Association(AHPBA) and the Association for Academic Surgery.

For more information, call: 773-296-7379